ELENA TEGGART MEDO
Chairman and CEO
Elena Medo is the CEO of Medolac Laboratories. Medo has dedicated her career to improving outcomes for preterm infants by using technology to increase access to lifesaving human milk. Medolac offers the first ready to feed, sterile, shelf stable human milk that can be shipped and stored at room temperature. Medo has raised over $35M for her last three life science startups, using disruptive innovation to achieve the goal of feeding the world’s 15 million preterm infants born each year. She holds numerous patents and her contributions to the space prior to Medolac include the development of the double breast pumping system, the first online milk bank, the first customized formulation of human milk to treat preterm infants and the first midrange IR human milk analyzer. Her innovative collaboration with co-founder and daughter, Adrianne Weir, led to a massive redesign of the milk banking business model, including the founding of the Mother’s Milk Cooperative enabling healthy nursing mothers to transact the sale of surplus milk in a safe and secure environment. The mission of the Company is to make human milk available to all babies in need, regardless of their economic status. Medo has an MBA from the Paul Merage School of Business at the University of California, Irvine where she also studied Computer Science and Developmental and Cell Biology as an Undergraduate.